Yongin-si, South Korea

Young Mee Chung

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 13.8

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Gyeonggi-do, KR (2005)
  • Suwon, KR (2005 - 2010)
  • Yongin-si, KR (2018)

Company Filing History:


Years Active: 2005-2018

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Young Mee Chung: Innovator in Pharmaceutical Chemistry

Introduction

Young Mee Chung is a distinguished inventor based in Yongin-si, South Korea, known for her significant contributions to pharmaceutical chemistry. With a remarkable portfolio of six patents, she has established herself as a leading figure in the research and development of innovative compounds aimed at addressing critical health issues.

Latest Patents

Among her latest inventions, Young Mee Chung has developed two noteworthy patents. The first is an amino-phenyl-sulfonyl-acetate derivative, along with its pharmaceutically acceptable salts. This invention is particularly promising as it relates to a pharmaceutical composition for preventing or treating diabetes. The second patent focuses on a thione derivative, presenting a 1,2,4-triazole derivative and a non-toxic salt thereof. This innovation also includes a preparation method and a pharmaceutical composition containing the derivative as an active ingredient, showcasing her dedication to advancing therapeutic solutions.

Career Highlights

Throughout her career, Young Mee Chung has made significant contributions to notable companies, including CJ Corporation and CJ Healthcare Corporation. Her work in these organizations has allowed her to apply her expertise and innovative thinking to the development of essential pharmaceutical products.

Collaborations

In her innovative journey, Young Mee Chung has collaborated with esteemed colleagues such as Il Hwan Cho and Dong Hyun Ko. These collaborations have fostered a creative environment, contributing to the success of various projects aimed at enhancing health outcomes through advanced pharmaceutical research.

Conclusion

Young Mee Chung exemplifies the spirit of innovation, with her patent portfolio reflecting her dedication to advancing pharmaceutical solutions. Through her tireless work and collaborations, she continues to pave the way for novel therapeutic approaches, particularly in the field of diabetes treatment and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…